Key result
Patients with the rs2200733 TT genotype had a significantly increased risk of atrial fibrillation recurrence after catheter ablation compared to those with the CC genotype (OR 2.03).
Why the study?
Does the presence of genetic variants rs2200733 and rs10033464 increase the risk of atrial fibrillation recurrence after catheter ablation in patients with atrial fibrillation?
Meta-Analysis (n=2,145)
Does the presence of genetic variants rs2200733 and rs10033464 increase the risk of atrial fibrillation recurrence after catheter ablation in patients with atrial fibrillation?
Genetic variants rs2200733 and rs10033464 on chromosome 4q25 are associated with an increased risk of atrial fibrillation recurrence after catheter ablation.
Answers are grounded in this paper and cite their sources.
May support genetic risk stratification for post-ablation AF recurrence; extends observational associations but should not yet change practice.
BACKGROUND: Common genetic polymorphisms at chromosome 4q25 were associated with increased susceptibility to atrial fibrillation (AF). However, it remained controversial whether these variants could be used as risk predictors for AF recurrence after catheter ablation. We therefore performed a metaanalysis to quantify the association between rs2200733 C>T/rs10033464 G>T and AF recurrence. METHODS: Relevant studies were systematically retrieved from PubMed, Web of Science, Elsevier database and Cochrane library through November 2016. Data were abstracted and pooled using Stata 12.0 software. RESULTS: A total of 2,145 patients undergoing catheter ablation were included. Patients with rs2200733 TT or TT+CT showed an overall increased susceptibility to AF recurrence (homozygous model [TT vs. CC]: odds ratio [OR] = 2.03, 95% confidence interval [CI] 1.49-2.76, p = 0.000; dominant model [TT+TC vs. CC]: OR = 1.48, 95% CI 1.17-1.87, p = 0.001; recessive model [TT vs. TC+CC]: OR = 1.88, 95% CI 1.12-3.15, p = 0.017). Subgroup analysis also identified a positive relation in Caucasians and late recurrence of AF in allelic, homozygous and dominant comparison. Moreover, a significant increased risk of AF recurrence was observed in patients with rs10033464 TG or TT+TG (heterozygous model [TG vs. GG]: OR = 1.46, 95% CI 1.01-2.12, p = 0.047; dominant model [TT+TG vs. GG]: OR = 1.51, 95% CI 1.04-2.17, p = 0.029). CONCLUSIONS: After catheter ablation, rs2200733 (TT or TT+TC) and rs10033464 (TT+TG or TG) were associated with increased risk of AF recurrence.
No takes yet. Share an insight, caveat, or question.
He et al. (2017) conducted a meta-analysis in Atrial fibrillation (n=2,145). rs2200733 TT genotype vs. rs2200733 CC genotype was evaluated on Atrial fibrillation recurrence (OR 2.03, 95% CI 1.49-2.76, p=0.000). Patients with the rs2200733 TT genotype had a significantly increased risk of atrial fibrillation recurrence after catheter ablation compared to those with the CC genotype (OR 2.03).
Synapse has enriched 10 related papers. Consider them for comparative context: